Delivery Order SPE2DX22D0010-SPE2D825FHS94
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $10,447.93 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,958.54 to AmerisourceBergen Drug Corp on August 13, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $11,379.98 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, valued at $3,634.86, represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle through December 2026. AmerisourceBergen, a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,060.18 to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply fulfillment. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply products. This firm fixed-price, non-set-aside contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,171.48 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,367.28 to AmerisourceBergen Drug Corp on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract issued to the prime contractor's Corporate Office division, located in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award was competitively procured with no set-aside...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHS94Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a $10,910.66 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this delivery order as part of its critical role in federal medical procurement for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999 IDC with DLA Troop Support Medical (designated SPE2DX) through December 2026, which serves as a global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract portfolio demonstrates its capability to meet competitive procurement requirements through open competition, delivering both brand-name and generic pharmaceuticals including specialty medications for conditions ranging from diabetes management to neurological treatment. This contract supports the Defense Health Agency's pharmaceutical supply chain and demonstrates AmerisourceBergen's position as a critical vendor within the government's medical logistics infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 8/18/25 |